Indivior to Report Fourth Quarter and Full-Year 2025 Financial Results and Host Webcast on February 26ᵗʰ
RICHMOND, Va., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) today announced that it will report its...
Brain
Global expansion of Idorsia’s QUVIVIQ continues with EMS partnership for Latin America
Ad hoc announcement pursuant to Art. 53 LR Regulatory dossier to obtain marketing authorization for QUVIVIQ has been submitted to...
AI Medical Imaging Revolution: Software-Native Tech Disrupts $45B Market
ISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD.VANCOUVER, BC, Jan. 27, 2026 /PRNewswire/ -- USANewsGroup.com News Commentary – The global medical imaging market...
BURL CONCEPTS ANNOUNCES FIRST HUMAN USES OF FOQUS™ ULTRASOUND SYSTEM FOR PATENT FORAMEN OVALE (PFO) DETECTION
Successfully identified PFOs in 30 patients across the Netherlands and UKFOQUS scans the whole brain for emboli in 40 seconds...
CNS Pharmaceuticals Issues Letter to Shareholders
Newly Appointed President & Chief Executive Officer, Rami Levin, Discusses Plans for a New Era at CNS PharmaceuticalsStrategic Focus, Pipeline...
ABLi Therapeutics Completes Collaboration Agreement with The Michael J. Fox Foundation to include Risvodetinib in Path to Prevention Platform Trial
Study aims to evaluate promising therapeutics that could slow or halt progression of Parkinson’s disease in prodromal patientsATLANTA and BOSTON,...
Synergy CHC Corp. (NASDAQ: SNYR) Expands FOCUSfactor® Functional Beverage Distribution Across Canada Through Walmart Canada and McKesson Canada
WESTBROOK, Maine, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a leading consumer...
Cognition Therapeutics Completes Type C Meeting with FDA for Zervimesine (CT1812) in Dementia with Lewy Bodies
PURCHASE, N.Y., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical stage...
GlassPoint Closes $20M Funding Round to Fuel Global Expansion of Solar Industrial Process Heat
N.I.S. New Investment Solutions leads investment in the leading provider of solar steamDUBAI, UAE, Jan. 26, 2026 /PRNewswire/ -- GlassPoint, the...
HearingLife Brings Oticon’s New Hearing Aid Style to Locations Nationwide
Oticon Zeal™ is the world's most discreet, complete hearing aidSOMERSET, N.J., Jan. 26, 2026 /PRNewswire/ -- HearingLife is proud to...
Minerva Neurosciences to Host Virtual KOL Event to Discuss Roluperidone: From Unmet Need to Reality – Potentially the First Treatment for Patients with Negative Symptoms of Schizophrenia, on February 3, 2026
BURLINGTON, Mass., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the...
Indivior Announces Completion of Redomiciliation to the United States
RICHMOND, Va., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (Nasdaq: INDV), today announced completion of its redomiciliation from...
HKUST President Prof. Nancy IP Engages in Global Dialogues at Davos 2026 on Neuroscience, University Leadership, and the Future of Research
HONG KONG, Jan. 26, 2026 /PRNewswire/ -- Prof. Nancy IP, President of The Hong Kong University of Science and Technology (HKUST),...
Nexalin Technology Receives Nasdaq Listing Status Notification
HOUSTON, TX, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL) (the “Company” or “Nexalin”), the leader in...
Consciousness Has No Limits: Small Healer Groups Override Random Devices Globally – Just by Meditating
Peer-reviewed research by Dr Joe Dispenza and HeartMath Institute reveals measurable global effects of emotionally coherent group meditationSAN DIEGO, Jan. 23,...
Consciousness Has No Limits: Small Healer Groups Override Random Devices Globally – Just by Meditating
Peer-reviewed research by Dr Joe Dispenza and HeartMath Institute reveals measurable global effects of emotionally coherent group meditationSAN DIEGO, Jan. 23,...
Nalu Announces Publication of Results from COMFORT Randomized Controlled Trial (RCT) Demonstrating Sustained Pain Relief and Functional Improvements Over 24 Months
CARLSBAD, Calif.--(BUSINESS WIRE)--#COMFORT24--The 24-month results of the COMFORT Peripheral Nerve Stimulation (PNS) RCT were published on January 23, 2026 in...
BrainTap Hits 2.2M Sessions and 46.6M Minutes Listened in 2025
Ignites 2026 with new ski-focused series from Dr. Tom LankeringNEW BERN, N.C., Jan. 22, 2026 /PRNewswire/ -- BrainTap, the leading provider...
Arbor Scientia Group Introduces an Innovative Educational Strategy to Assist Their Pharmaceutical Clients in Driving Measurable Learning Outcomes
Arbor Scientia Group has been assisting clients with a new online educational excellence course model designed to improve engagement, retention, and...
NKGen Biotech Names Leading Dementia Expert Bruce L. Miller, M.D. to Scientific Advisory Board
Dr. Miller’s appointment further enhances NKGen’s scientific and clinical advisory capabilities as the Company advances its research in Alzheimer’s and...